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echocardiographic estimation of pulmonary artery pressure and other echocarciographic
and clinical features in 175 consecutive adult SSD patients (74 male, 101 female, mean
age = 37 ± 11 years) recruited from a local hospital and community clinics who were fol-
lowed for a median period of 12 months.
Methods: PH was prospectively defined as a tricuspid regurgitation jet velocity of > 2.5 m/
sec. 2-Dimensional assessment of chamber dimensions and ventricular systolic perfor-
mance, pulsed Doppler quantitation of left ventricular stroke volume, continuous wave
Doppler estimation of pulmonary artery systolic pressure, and right ventricular systolic
and diastolic function (dP/dt from TR spectral trace) were examined.
Results. PH was present in 33 % of patients and peak TR velocities (TRV) > 3 m/sec
were observed in 9%. In univariate analysis, TRV was the strongest predictor of all-cause
mortality (relative risk 8.3; 95% CI = 1.7 to 40; P = 0.003). TRV did not correlate with left
ventricular ejection fraction, stroke volume or cardiac output. Patients with TRV > 2.5 m/
sec had significantly larger right atrial areas (20 ± 5 vs 18± 4 cm2, P < 0.001, values are
mean + SD) and evidence of right ventricular systolic and diastolic dysfunction (+dP/dt;
419 ± 139 vs 659 ± 371 mmHg/sec, P < 0.01 and –dP/dt; 157 ± 52 vs 236 ± 77 mmHg/
sec, P < 0.001). Ventricular volumes, ejection fraction, and severity of mitral regurgitation
were similar between groups as were non-echo SSD parameters including fetal hemoglo-
bin, white blood cell and platelet counts, and hydroxyurea use.
Conclusion: Secondary pulmonary hypertension is a powerful independent predictor of
mortality in SSD, is unrelated to cardiac output and is associated with abnormalities in
RV systolic and diastolic function. Echocardiography can be used as a screening tool to
identify a high risk subgroup in SSD that may benefit from therapeutic interventions.
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Purpose: We sought to determine the cost-effectiveness of screening coronary artery
disease (CAD) patients with B-type natriuretic peptide (BNP) to identify those with low left
ventricular ejection fraction (EF).
Methods: We constructed a decision tree that compared screening with BNP with follow-
up echocardiography (echo) in those with a high BNP to no screening. We estimated
economic and health outcomes using a Markov-model based on data from the SOLVD
treatment and prevention trials. We determined the sensitivity (67%) and specificity
(78%) of BNP (Biosite, threshold 100 pg/ml) for the detection of an EF < 40% using data
from 293 patients with coronary artery disease and no history of heart failure.
Results: The population for the base case had mean age of 69 years and 92% were
male. The prevalence of EF below 40% was 3.1%. Screening 1000 CAD patients with
BNP followed by echo in those with a BNP > 100 pg/dl increased the cost of care by
$216,000, and improved outcome by 7.2 quality adjusted life years ($30,000/QALY).
Screening with echo in all patients provided greater outcome compared to first testing
with BNP (3.3 QALYs) but cost an additional $445,000 ($135,000/QALY). The cost-effec-
tiveness of screening was most sensitive to the prevalence of low ejection fraction (Fig-
ure). If the prevalence is over 1.5%, screening increases outcome at a cost less than
$50,000/QALY gained.
Conclusion: Screening men with CAD for low EF with BNP improves outcome at a cost
that is less than other accepted medical treatments.
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Coronary angiography (Angio) is a frequently performed procedure in women, with non-
obstructive (<50% stenosis ) coronary disease (CAD) often noted.
We examined CAD prognosis and costs in 887 women undergoing Angio. Events, hospi-
talizations, and drug use was recorded during annual visits. Costs were discounted (5%/
year [yr]), inflated (yr 2002), projected through lifetime, and compared using general lin-
ear models (adjusted for race, income, marital status, and insurance).
Of the 887 women, 62%, 17%, 11%, and 10% had <50% stenosis, and 1, 2, and 3 vessel
CAD. During 4-yrs of follow-up, 44 deaths, 18 MIs, and 155 angina hospitalizations were
observed. In a risk-adjusted Cox model (adjusted for risk factors and symptoms), annual
death or MI rates were 0.9% for women with <50% stenosis versus (vs) 2.3%-6.0% for
those with 1-3 vessel CAD (p=0.001). Angina hospitalization rates were 14% and 25% for
women with < vs >50% stenosis (p=0.03). After yr 1, repeat Angio or angina hospitaliza-
tion was 1.8-fold higher in women with <50% stenosis vs 1 vessel CAD women
(p<0.0001). 4-yr mean±standard deviation costs (x $1,000) ranged from $13±$16 to
$27±$25 for 0 to 3 vessel CAD (p<0.0001). Due to a younger age at Angio, lifetime costs
were $206,246 for women with <50% stenosis increasing to $540,136 for those with 3
vessel CAD (Figure).
In conclusion, symptom-driven care for women is costly even in the absence of obstruc-
tive CAD. The societal economic burden for CAD care in women with angina could range
from $244-$966 billion dollars.
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Background: The purpose of this pilot study was to examine the use of simulation as a
tool for teaching coronary angiography and angioplasty techniques to Fellows in the Peo-
ples Republic of China.
Methods: The angiography and angioplasty simulator was designed and developed
using a systematic approach. First, a detailed description of 10 different clinical cases
were developed and reviewed for content and accuracy by several experienced Interven-
tional Cardiologists. Each Procedure Description was then broken down into the finite
constituent tasks a Cardiologist must perform in order to successfully perform angiogra-
phy and angioplasty. The tasks were then analyzed to ascertain their performance
domain (cognitive, psychomotor) with particular emphasis on those aspects of perfor-
mance which are prone to error. This Task Analysis was then reviewed by Interventional
Cardiologists, revised, and became the metric for the development of the simulator. In
November 2002, six simulators were used as part of a 5 day seminar for 23 Cardiology
Fellows in Beijing, and again in February 2003. Experienced Cardiologists from the
United States and China served as faculty. The seminars consisted of didactic lectures
followed by practice and feedback sessions on the simulators. At the end of each day stu-
dent progress and performance was reviewed by Faculty. In addition, the candidates
completed seminar evaluation forms.
Results: The faculty members felt that the simulation content was valid, in that it suffi-
ciently replicated interventional procedures to provide useful and valuable training. Sub-
jectively, the system was able to quickly discriminate between master and novice
performers. Candidates demonstrated substantial improvement in the performance of
targeted tasks, particularly in the areas of refining angiographic views and interventional
tool manipulation.
Conclusion: This pilot study demonstrated that simulation, when properly designed and
integrated into a curriculum, is accepted by Cardiologists as a training tool, and that it has
the propensity to markedly improve the performance of Fellows. Follow-on formal studies
are planned to document concurrent and predictive validity.
